These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7015792)

  • 1. Haloperidol, thioridazine and placebo in mentally subnormal patients-serum levels and clinical effects.
    Väisänen K; Viukari M; Rimón R; Räisänen P
    Acta Psychiatr Scand; 1981 Mar; 63(3):262-71. PubMed ID: 7015792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled double-blind study of haloperidol versus thioridazine in the treatment of restless mentally subnormal patients. Serum levels and clinical effects.
    Väisänen K; Rimón R; Räisänen P; Viukari M
    Acta Psychiatr Belg; 1979; 79(6):673-85. PubMed ID: 554446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical evaluation of mesoridazine in mentally retarded patients.
    Zaleski W
    Can Psychiatr Assoc J; 1970 Jun; 15(3):319-22. PubMed ID: 4913609
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of anticonvulsants on plasma haloperidol and thioridazine levels.
    Linnoila M; Viukari M; Vaisanen K; Auvinen J
    Am J Psychiatry; 1980 Jul; 137(7):819-21. PubMed ID: 6770696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thioridazine on the intellectual performance of mentally retarded drug responders and nonresponders.
    Breuning SE; Ferguson DG; Davidson NA; Poling AD
    Arch Gen Psychiatry; 1983 Mar; 40(3):309-13. PubMed ID: 6338856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very low-dose neuroleptic treatment in two patients with agitation associated with Alzheimer's disease.
    Risse SC; Lampe TH; Cubberley L
    J Clin Psychiatry; 1987 May; 48(5):207-8. PubMed ID: 2883174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.
    Salih IS; Thanacoody RH; McKay GA; Thomas SH
    Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationships between psychotropic drug dosage, plasma drug concentration, and prolactin levels in nursing home residents.
    Cohen-Mansfield J; Taylor L; Woosley R; Lipson S; Werner P; Billig N
    Ther Drug Monit; 2000 Dec; 22(6):688-94. PubMed ID: 11128236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.
    Aman MG; Teehan CJ; White AJ; Turbott SH; Vaithianathan C
    Am J Ment Retard; 1989 Jan; 93(4):452-60. PubMed ID: 2649118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of single-double blind procedures, maintenance of placebo effects and drug induced dyskinesia with mentally retarded persons.
    Breuning SE; Ferguson DG; Cullari S
    Appl Res Ment Retard; 1980; 1(3-4):175-92. PubMed ID: 7337456
    [No Abstract]   [Full Text] [Related]  

  • 12. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study.
    Cohen-Mansfield J; Lipson S; Werner P; Billig N; Taylor L; Woosley R
    Arch Intern Med; 1999 Aug 9-23; 159(15):1733-40. PubMed ID: 10448776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma neuroleptic and prolactin levels in mentally retarded patients.
    Linnolia M; Viukari M; Vaisanen K; Auvinen J
    Acta Pharmacol Toxicol (Copenh); 1980 Feb; 46(2):159-60. PubMed ID: 6102427
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of thioridazine dosage on the behavior of severely mentally retarded persons.
    Singh NN; Aman MG
    Am J Ment Defic; 1981 May; 85(6):580-7. PubMed ID: 7023237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effects of thioridazine, flupenthixol and haloperidol on serum catalase activity in schizophrenia].
    Zapletálek M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1977; 20(2-3):197-204. PubMed ID: 305641
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
    Greendyke RM; Kanter DR
    J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of haloperidol and thioridazine in treatment resistant psychoneurotic outpatients.
    Lingl FA
    Psychosomatics; 1973; 14(4):235-40. PubMed ID: 4604344
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE; Davis VJ; Matson JL; Ferguson DG
    Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.